Serial Number | 97910441 |
Word Mark | ERVIMMUNE |
Filing Date | Thursday, April 27, 2023 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 9, 2024 |
Registration Number | 7444894 |
Registration Date | Tuesday, July 9, 2024 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology; all aforementioned goods not for use in the field of medical diagnostics |
Goods and Services | Medical and surgical services in the field of immunotherapy and oncology; medical testing for treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the treatment of persons; genetic testing services for medical purposes; all aforementioned services not for use in the field of medical diagnostics |
Goods and Services | Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy; all aforementioned services not for use in the field of medical diagnostics |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 25, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 25, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 25, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Ervaccine Technologies |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Lyon Cedex 08 69373 FR |
Party Name | Ervaccine Technologies |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Lyon Cedex 08 69373 FR |
Event Date | Event Description |
Monday, November 13, 2023 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Monday, May 1, 2023 | NEW APPLICATION ENTERED |
Thursday, May 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 8, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, November 13, 2023 | ASSIGNED TO LIE |
Wednesday, January 24, 2024 | ASSIGNED TO EXAMINER |
Thursday, January 25, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, January 25, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, January 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, February 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, February 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, May 28, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, April 4, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, April 4, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, April 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 28, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, May 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 31, 2024 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
Tuesday, July 9, 2024 | REGISTERED-SUPPLEMENTAL REGISTER |
Tuesday, July 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |